Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

NCT00643097 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasms of Brain

Interventions

BIOLOGICAL: PEP-3 vaccine
BIOLOGICAL: sargramostim
DRUG: Temozolomide

Sponsor

John Sampson

Collaborators

[object Object]